Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cell-derived exosome injection for chronic rhinosinusitis with nasal polyposis
IRCT20130812014333N228Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Oct 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mesenchymal stem cell exosomes in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Allergy symptoms and Polyp size. Started Oct 2024; status: completed.
02
Drugs
mesenchymal stem cell exosomes
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20130812014333N228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N228.